Home›Stocks›NAMS

NAMS — structural market context

NewAmsterdam Pharma Company N.

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

NAMS short interest & days to cover

SHARES SHORT

10.0M

% OF FLOAT

—

DAYS TO COVER

9.8

CHANGE VS PRIOR

+8.5%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-07-31 (26d ago)

NAMS fails-to-deliver (FTD)

Settlement date	Failed shares	Price
2026-07-29 · 28d	138	$27.98
2026-07-24 · 33d	500	$30.55
2026-07-23 · 34d	500	$31.7

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

NAMS insider buying and selling (Form 4)

Last 12 months, open-market only: 0 purchases · 1 sale

Insider	Type	Shares	Value	Filed
Kastelein Johannes Jacob Pieter · director, officer: Chief Scientific Officer	Sell (S)	125K	$3.4M	2026-08-25

SEC Form 4 filings, open-market purchases and sales only (codes P and S); grants and option exercises excluded. Attributed public records.

Frequently asked questions

Are insiders buying NAMS?

In the last 12 months of SEC Form 4 filings, NAMS recorded 0 open-market insider purchases and 1 open-market sale (codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.

Is this page telling me to buy or sell NAMS?

No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.

All covered stocks Short Interest & FTD tracker Insider Buying tracker Analyst Accuracy tracker The platform

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.